grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

October 26, 2016

Leading Academic Medical Centers Upgrade Medication Management Technology to Increase Patient Safety and Promote Innovation

Download PDF

MOUNTAIN VIEW, Calif., Oct. 26, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced a partnership with two prestigious academic medical centers to enhance clinical staff workflows and foster improved patient care. Both Dartmouth-Hitchcock (Lebanon, N.H.) and Stanford Health Care (Palo Alto, Calif.) are deploying the Company's solutions to upgrade medication management technology to optimize patient outcomes.

Omnicell, Inc. logo

Academic medical centers play a leadership role in improving the standards of medication delivery and patient care to ensure the healthiest, fastest, and safest discharge. Managing medications from arrival into the hospital, through the hospital-based pharmacy to the patient bedside is a key component to the success of this process. Additionally, having solutions that are interoperable with other systems in the hospital, including the electronic health record, helps streamline workflows for nurses and other providers so they are able to spend more time with the patient as opposed to navigating administrative tasks.

Stanford Health Care will replace its existing dispensing cabinets with Omnicell solutions, with plans to install similar automated medication management technologies in its new hospital that is expected to be completed by 2018. It also plans to add new solutions to promote enhanced security for controlled substances in the next few months to improve workflows and ensure medication safety in the operating room.

By updating its medication management technology, Dartmouth-Hitchcock maintains its dedication to hospital security and safety. The hospital network serves patients across northern New England, and will be implementing technology that includes central pharmacy automation, enterprise medication management capabilities, and automated medication dispensing on hospital floors. These technologies support enterprise-wide visibility of inventory and set the stage for optimizing operations across numerous health facilities.

Beyond the focus on short-term planning, hospitals today are trying to forecast how care might change over the next 25 years. With more attention being paid to physical environments and how patients move within the hospital, there is a renewed focus on making jobs easier for all employees who engage patients - whether doctors, nurses, pharmacists, or administrators. Omnicell automation, which includes unique features for simplifying the medication management process, supports the goal of enabling greater patient interaction by reducing the amount of time spent on administrative and other non-patient facing activities.

"As we expand to serve over 4,000 hospitals in the U.S., we're pleased to support these prestigious academic institutions on both sides of the country. Interoperability and optimal medication management are central to not just academic facilities, but all hospitals looking to streamline workflows and improve patient safety," said J. Christopher Drew, president, North American Automation and Analytics at Omnicell. "Both institutions embody innovation as they continue to make advancements in the medical field to deliver excellent patient care. We embrace the opportunity to meet the short- and long-term needs of these facilities."

About Dartmouth-Hitchcock

DARTMOUTH-HITCHCOCK (D-H) is a nonprofit academic health system serving communities in northern New England. D-H provides access to more than 1,000 primary care doctors and specialists in almost every area of medicine at Dartmouth-Hitchcock Medical Center; the Norris Cotton Cancer Center, the Children's Hospital at Dartmouth-Hitchcock, four affiliate hospitals, 24 ambulatory clinics and through the Visiting Nurse and Hospice for VT and NH. The D-H system trains nearly 400 residents and fellows annually, and performs world-class research, in partnership with the Audrey and Theodor Geisel School of Medicine at Dartmouth and the White River Junction VA Medical Center.

About Stanford Health Care

Stanford Health Care seeks to heal humanity through science and compassion, one patient at a time, through its commitment to care, educate and discover. Stanford Health Care delivers clinical innovation across its inpatient services, specialty health centers, physician offices, virtual care offerings and health plan programs.

Stanford Health Care is part of Stanford Medicine, a leading academic health system that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children's Health, with Lucile Packard Children's Hospital. Stanford Medicine is renowned for breakthroughs in treating cancer, heart disease, brain disorders and surgical and medical conditions. For more information, visit:

About Omnicell

Since 1992, Omnicell (NASDAQ : OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served via the Company's sales channels and our solutions enable them to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Omnicell, Inc.

News Provided by Acquire Media